CHRISTIAN CRAWFORD: Open Payments
NPI 1427303478 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$559 in 32 payments from 14 companies in 2025. Trend: 2023 $50 · 2024 $201 · 2025 $559
Food & beverage: $559
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $139 |
| ABBVIE INC. | 4 | $93 |
| Lilly USA, LLC | 4 | $64 |
| Exact Sciences Corporation | 2 | $48 |
| Amgen Inc. | 2 | $44 |
| Stryker Corporation | 1 | $34 |
| Novo Nordisk Inc | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Exeltis, USA Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: PREVNAR 20, UBRELVY, NURTEC ODT, Cologuard Collection Kit, MOUNJARO, MAKO, QULIPTA, Wegovy.
Industry payments across ID — which companies pay providers there.
